Teva Pharma Says Allergan Generics Deal Delayed

Mar 16, 2016

Reuters

Teva Pharmaceutical Industries said it now expects its $40.5 billion acquisition of Allergan to be completed by June, according to a Reuters article. Previously the deal was supposed to close by the end of the first quarter with a possible delay into April.

"Teva now anticipates that completing the acquisition could take as long as June 2016, based upon its current estimate of the timing to obtain clearance from the United States Federal Trade Commission," the company said in a statement. Read the Reuters story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments